DFG to fund nine clini...( notherapy. Their clinical trial Adopti...)

notherapy. Their clinical trial "Adoptive Immunotherapy for Adenovirus Associated Complications Post Transplantation" focuses on affected children and young people between the age of 2 and 18.
(Total funding: 957,824. Coordinator: Dr. Sebastian Voigt, Charit University Hospital, Berlin)

In the clinical trial "Bone Marrow Transfer to Enhance ST-elevation Infarct Regeneration-2 (BOOST-2)" a team from Hannover and Hildesheim, together with cardiologists from Gttingen, Berlin and Heidelberg, are researching whether or not an infusion of bone marrow cells into the coronary vessels can improve heart function after a heart attack. Whether the infusion of bone marrow cells actually does result in an improvement is the topic of heated debate worldwide. This trial will contribute significantly to answering this question.
(Total funding: 987,063. Coordinator: Prof. Helmut Drexler, Hannover Medical University)

Scientific studies have proven the effectiveness of antidepressants. However, it has not yet been shown that additional cognitive-behavioural therapy, or CBT, is successful in the long term. Psychologists and psychotherapists from Jena, Frankfurt/Main, Mainz, Erlangen and Tbingen are attempting to close this gap with the clinical trial "Combined Cognitive-behavioural and Pharmacological Continuation and Maintenance Treatment of Recurrent Depression".
(Total funding: 709,600. Coordinator: Prof. Ulrich Stangier, University of Jena)

Patients with schizophrenia often not only suffer from the so-called "positive" symptoms typical of this disease, such as delusions and hallucinations. They are also impaired by "negative" symptoms (lack of initiative, emotional vacancy and depression). The clinical trial Cognitive-behavioural Treatment of Negative Symptoms in Patients with Schizophrenic Disorders" being carried out by the University of Tbingen is intended to clarify whether cognitive-behavioural therapy is effective in treating these ne
'"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
13-Sep-2005

Page: 1 2 3 4
Related biology news :

1. Preclinical study links gene to brain aneurysm formation
2. Gene variant is associated with brain anatomy, clinical course of ADHD
3. New joint replacement material developed at MGH put to first clinical use
4. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
5. From clinical cancer research: rethinking therapeutic cancer vaccine trials
6. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
7. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
8. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
9. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
10. BDSI announces positive phase III clinical trial results
11. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial